Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
about
Plasmacytoid dendritic cells: linking innate and adaptive immunityThe inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12Plasmacytoid dendritic cells and type I IFN: 50 years of convergent historyBlastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells.TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFNTargeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.TLR9 activation is triggered by the excess of stimulatory versus inhibitory motifs present in Trypanosomatidae DNA.A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy.Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X.What is CD4+CD56+ malignancy and how should it be treated?Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN ProductionIkaros is required for plasmacytoid dendritic cell differentiation.Characterization of species-specific genes regulated by E2-2 in human plasmacytoid dendritic cellsA Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile.Good clinical response in a rare aggressive hematopoietic neoplasm: plasmacytoid dendritic cell leukemia with no cutaneous lesions responding to 4 donor lymphocyte infusions following transplant.Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapyDendritic cell homeostasis.The Janus face of dendritic cells in cancer.Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms.Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature.Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies.Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.Transplantation in rare lymphoproliferative and histiocytic disorders.A case of blastic plasmacytoid dendritic cell neoplasm initially mimicking cutaneous lupus erythematosus
P2860
Q24558695-1A6EBE5A-6E86-4923-98EF-DDE3D5313C58Q24672653-E11E577D-5501-48C4-A49E-8AC403F6C2C2Q27485637-2FCA398B-78EF-4226-8D02-5F5501E429E8Q30249813-8996B384-0DA1-4B97-AF82-DD42E436ED34Q33415505-2A70C76E-1763-49F8-B23C-9E7D7EF796A8Q33417051-9668DE0C-70ED-49C3-AD3B-695E3AB186E0Q33505665-4597A632-C75B-409B-89C2-F71B237701A4Q33763210-3AAA04FE-5708-46B4-84E2-DC29BAE3276DQ34227741-B49D9D2C-ADD3-4476-807A-2ED16F0762C9Q34255104-44FB8703-2281-446B-BEAF-24AD90540AF8Q34505652-280D41FC-03C4-454A-BDF4-5B5F82EA05B4Q34538446-51D1CC05-4333-4DDC-91B4-DD7490EA804BQ35060665-F4CA5518-810C-42BB-A643-D18002A2EF7FQ35104381-08635D32-8AF6-411F-9807-BBE80276DFD2Q35226503-32ED25E9-FE98-45EF-9399-ADE9642DC9DEQ35252280-7FF82A5F-B2FC-492E-AD4B-25CE78D485CCQ35746343-480D2512-2BE2-4C5B-A8B1-5E48D7519EA2Q35848777-1753383B-5BE4-4718-919D-FCA5F28E6673Q35860245-38929508-3D89-467B-B187-9AB71065526EQ36193086-99B33250-3746-4E94-BE82-2DAAA0C20287Q36326361-18E9F521-300F-4EEF-AE43-98FC9DE79114Q36417590-3CC0CFDC-6E73-441D-9DCE-912ADD9FACDAQ36455996-DD35168D-B902-4320-95FC-8C8A80CE55CFQ36579106-8CC6FC0D-D164-4CA5-87D3-7084B7D1EBACQ36715919-5F79500A-12E1-411F-B2FC-1CF94880058AQ36762575-514ADA36-5BE4-4BEE-8B63-48BCEFFDF000Q37082729-CC0C3664-9574-4E49-A224-CA88734F3EC4Q37157975-8871E104-4F31-4D82-8654-2EAEC4B13F49Q37287170-E8EAD628-8FA9-4D91-8AC3-DC330B6A3069Q37299013-F814524A-D499-469B-80E7-79FF674DF3B4Q37619948-F822B5EC-789A-484B-9CAB-8AE251398D4FQ37684743-3F4A2C3D-C3B1-436D-95B5-6AB3FE15E91AQ37997833-92423577-C2B4-4877-AEFD-250E71790760Q38031280-6E3489A3-5C41-4828-A52A-171EE4ECB115Q38058425-0B2AA5E0-FD5E-4EFB-A882-4C7658CC8F6BQ38186870-104E7299-83F3-4174-AAA9-540B0DE00A62Q38213642-F6704C90-F263-4AF7-99BC-9A11F62637D9Q38259612-6EE2213A-48BD-41E6-87C7-6398C5B90E31Q38259618-5FE14033-371E-4CD6-BAE7-BB1D8456F977Q38477865-F372E094-5150-42A7-BB90-8EF75166130F
P2860
Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
@en
Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
@nl
type
label
Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
@en
Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
@nl
prefLabel
Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
@en
Identification of a leukemic counterpart of the plasmacytoid dendritic cells.
@nl
P2093
P50
P1433
P1476
Identification of a leukemic counterpart of the plasmacytoid dendritic cells
@en
P2093
F Trimoreau
H Orfeuvre
M Maynadie
N Bendriss
P304
P356
10.1182/BLOOD.V97.10.3210
P407
P577
2001-05-01T00:00:00Z